MoneyWorks4Me

Sanjivani Paranteral - Quaterly Results

05 Feb 2024 Evaluate
The turnover soared 64.03% to Rs. 149.63 millions for the December 2023 quarter as compared to Rs. 91.22 millions during the corresponding quarter last year.The Profit  for the quarter ended December 2023 of  Rs. 16.51  millions  grew by 73.42% from Rs. 9.52 millions.Operating profit surged to 22.13 millions from the corresponding previous quarter of 12.32 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 149.63 91.22 64.03 415.47 273.70 51.80 354.92 306.13 15.94
Other Income 2.54 3.10 -18.06 4.64 5.93 -21.75 5.54 2.43 127.98
PBIDT 22.13 12.32 79.63 65.48 48.05 36.27 61.90 59.69 3.70
Interest 0.77 0.54 42.59 1.66 2.00 -17.00 3.59 2.13 68.54
PBDT 21.36 11.78 81.32 63.82 46.05 38.59 58.31 57.56 1.30
Depreciation 2.35 2.26 3.98 6.96 6.60 5.45 8.88 8.77 1.25
PBT 19.01 9.52 99.68 56.86 39.45 44.13 49.43 48.79 1.31
TAX 2.50 0.00 0.00 7.80 4.31 80.97 4.33 0.32 1253.13
Deferred Tax 0.00 0.00 0.00 0.00 -0.69 -100.00 -6.10 0.32 -2006.25
PAT 16.51 9.52 73.42 49.06 35.14 39.61 45.10 48.47 -6.95
Equity 99.98 99.98 0.00 99.98 99.98 0.00 99.98 99.98 0.00
PBIDTM(%) 14.79 13.51 9.51 15.76 17.56 -10.23 17.44 19.50 -10.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..